The Therapeutic Goods Administration (TGA) has provisionally approved two oral antiviral treatments for COVID-19. Here’s what pharmacists need to know.

The TGA has told pharmacists, prescribers and patients to expect a shortage of Estradot (estradiol) HRT transdermal products until July 2021.

In line with TGA regulatory changes to enhance medicine safety, PSA has developed a cautionary advisory label that warns consumers about the risk of opioid overdose and dependence.

The Therapeutic Goods Administration (TGA) has reviewed their proposal to upschedule all alkyl nitrites to Schedule 9 (S9), but pharmacists will need to ensure...

Data from the National Notifiable Diseases Surveillance System reveals cases of cryptosporidiosis have skyrocketed in 2024.

The landscape for glucagon-like peptide-1 receptor agonists (GLP-1RAs) used for weight loss is changing in Australia as demand continues to grow.